Abstract
Spinal muscular atrophy (SMA) is an autosomal recessive (AR) neuromuscular disease that is one of the most common lethal genetic disorders in children, with carrier frequencies as high as ∼1 in 35 in US Whites. As part of our genetic studies in the Hutterites from South Dakota, we identified a large 22 Mb run of homozygosity, spanning the SMA locus in an affected child, of which 10 Mb was also homozygous in three affected Hutterites from Montana, supporting a single founder origin for the mutation. We developed a haplotype-based method for identifying carriers of the SMN1 deletion that leveraged existing genome-wide SNP genotype data for ∼1400 Hutterites. In combination with two direct PCR-based assays, we identified 176 carriers of the SMN1 deletion, one asymptomatic homozygous adult and three carriers of a de novo deletion. This corresponds to a carrier frequency of one in eight (12.5%) in the South Dakota Hutterites, representing the highest carrier frequency reported to date for SMA and for an AR disease in the Hutterite population. Lastly, we show that 26 SNPs can be used to predict SMA carrier status in the Hutterites, with 99.86% specificity and 99.71% sensitivity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Hendrickson BC, Donohoe C, Akmaev VR et al: Differences in SMN1 allele frequencies among ethnic groups within North America. J Med Genet 2009; 46: 641–644.
Prior TW, Snyder PJ, Rink BD et al: Newborn and carrier screening for spinal muscular atrophy. Am J Med Genet A 2010; 152A: 1608–1616.
Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K : Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 1997; 61: 40–50.
Wirth B : An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 2000; 15: 228–237.
Martín Y, Valero A, del Castillo E, Pascual SI, Hernández-Chico C : Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations. Hum Genet 2002; 110: 257–263.
Parsons DW, McAndrew PE, Iannaccone ST, Mendell JR, Burghes AH, Prior TW : Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. Am J Hum Genet 1998; 63: 1712–1723.
Mailman MD, Heinz JW, Papp AC et al: Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002; 4: 20–26.
Wirth B, Herz M, Wetter A et al: Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. Am J Hum Genet 1999; 64: 1340–1356.
Oprea GE, Kröber S, McWhorter ML et al: Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science (New York, NY) 2008; 320: 524–527.
Monani UR, Sendtner M, Coovert DD et al: The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(−/−) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 2000; 9: 333–339.
Prior TW : Perspectives and diagnostic considerations in spinal muscular atrophy. Genet Med 2010; 12: 145–152.
Wirth B, Schmidt T, Hahnen E et al: De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet 1997; 61: 1102–1111.
Martin AO : The founder effect in a human isolate: evolutionary implications. Am J Phys Anthropol 1970; 32: 351–367.
Boycott KM, Parboosingh JS, Chodirker BN et al: Clinical genetics and the Hutterite population: a review of Mendelian disorders. Am J Med Genet 2008; 146A: 1088–1098.
Romero IG, Ober C : CFTR mutations and reproductive outcomes in a population isolate. Hum Genet 2008; 122: 583–588.
Ober C, Tan Z, Sun Y et al: Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008; 358: 1682–1691.
Ober C, Aldrich CL, Chervoneva I et al: Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003; 72: 1425–1435.
Ober C, Abney M, Mcpeek M : The genetic dissection of complex traits in a founder population. Am J Hum Genet 2001; 69: 1068–1079.
Bourgain C, Abney M, Schneider D, Ober C, McPeek MS : Testing for Hardy-Weinberg equilibrium in samples with related individuals. Genetics 2004; 168: 2349–2361.
Purcell S, Neale B, Todd-Brown K et al: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
Kong A, Masson G, Frigge ML et al: Detection of sharing by descent, long-range phasing and haplotype imputation. Nat Genet 2008; 40: 1068–1075.
Gómez-Curet I, Robinson KG, Funanage VL, Crawford TO, Scavina M, Wang W : Robust quantification of the SMN gene copy number by real-time TaqMan PCR. Neurogenetics 2007; 8: 271–278.
McAndrew PE, Parsons DW, Simard LR et al: Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997; 60: 1411–1422.
Friedman J, Hastie T, Tibshirani R : Regularization paths for generalized linear models via coordinate descent. J Stat Softw 2010; 33: 1–22.
Prior TW, Krainer AR, Hua Y et al: A positive modifier of spinal muscular atrophy in the SMN2 gene. Am J Hum Genet 2009; 85: 408–413.
Helmken C, Hofmann Y, Schoenen F et al: Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum Genet 2003; 114: 11–21.
Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ : Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am J Med Genet A 2004; 130A: 307–310.
Cobben JM, van der Steege G, Grootscholten P, de Visser M, Scheffer H, Buys CH : Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet 1995; 57: 805–808.
Wang CH, Xu J, Carter TA et al: Characterization of survival motor neuron (SMNT) gene deletions in asymptomatic carriers of spinal muscular atrophy. Hum Mol Genet 1996; 5: 359–365.
Feldkötter M, Schwarzer V, Wirth R, Wienker TF, Wirth B : Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358–368.
Pyatt RE, Mihal DC, Prior TW : Assessment of liquid microbead arrays for the screening of newborns for spinal muscular atrophy. Clin Chem 2007; 53: 1879–1885.
Prior TW, Professional Practice and Guidelines Committee: Carrier screening for spinal muscular atrophy. Genet Med 2008; 10: 840–842.
Cuscó I, Barceló MJ, del Rio E et al: Characterisation of SMN hybrid genes in Spanish SMA patients: denovo, homozygous and compound heterozygous cases. Hum Genet 2001; 108: 222–229.
Raclin V, Veber PS, Bürglen L, Munnich A, Melki J : De novo deletions in spinal muscular atrophy: implications for genetic counselling. J Med Genet 1997; 34: 86–87.
Melki J, Lefebvre S, Burglen L et al: De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 1994; 264: 1474–1477.
Hofmann Y, Lorson CL, Stamm S, Androphy EJ, Wirth B : Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci USA 2000; 97: 9618–9623.
ACOG Committee on Genetics: ACOG committee opinion No. 432: spinal muscular atrophy. Obstet Gynecol 2009; 113: 1194–1196.
Cusin V, Clermont O, Gérard B, Chantereau D, Elion J : Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling. J Med Genet 2003; 40: e39.
Little SE, Janakiraman V, Kaimal A, Musci T, Ecker J, Caughey AB : The cost-effectiveness of prenatal screening for spinal muscular atrophy. Am J Obstet Gynecol 2010; 202: 253.e1–253.e7.
Miller SR, Schwartz RH : Attitudes toward genetic testing of Amish, Mennonite, and Hutterite families with cystic fibrosis. Am J Public Health 1992; 82: 236–242.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Chong, J., Oktay, A., Dai, Z. et al. A common spinal muscular atrophy deletion mutation is present on a single founder haplotype in the US Hutterites. Eur J Hum Genet 19, 1045–1051 (2011). https://doi.org/10.1038/ejhg.2011.85
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2011.85
Keywords
This article is cited by
-
Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review
Orphanet Journal of Rare Diseases (2017)
-
Disclosure of Genetic Research Results to Members of a Founder Population
Journal of Genetic Counseling (2014)
-
Estimating the human mutation rate using autozygosity in a founder population
Nature Genetics (2012)
